BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 17916567)

  • 1. Suppression of metallothionein 3 gene expression by androgen in LNCaP prostate cancer cells.
    Otsuka T; Hamada A; Iguchi K; Usui S; Hirano K
    Biomed Rep; 2013 Jul; 1(4):614-618. PubMed ID: 24648996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin β4 improves the survival of cutaneous flaps of rats and activates the Wnt/β-catenin pathway.
    Tao X; Pan X; Xue M; Zhao G; Rui Y
    Arch Med Sci; 2024; 20(2):708-712. PubMed ID: 38757041
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate tissue metal levels and prostate cancer recurrence in smokers.
    Neslund-Dudas C; Kandegedara A; Kryvenko ON; Gupta N; Rogers C; Rybicki BA; Dou QP; Mitra B
    Biol Trace Elem Res; 2014 Feb; 157(2):107-12. PubMed ID: 24385087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract.
    Nemolato S; Cabras T; Fanari MU; Cau F; Fanni D; Gerosa C; Manconi B; Messana I; Castagnola M; Faa G
    Eur J Histochem; 2010 Oct; 54(4):e43. PubMed ID: 21263742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.
    Li Y; Wang L; Zhang M; Melamed J; Liu X; Reiter R; Wei J; Peng Y; Zou X; Pellicer A; Garabedian MJ; Ferrari A; Lee P
    Cancer Res; 2009 Apr; 69(8):3332-8. PubMed ID: 19351848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
    Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
    Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
    Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of thymosin beta4 expression by androgen in prostate cancer LNCaP cells.
    Iguchi K; Ito M; Usui S; Mizokami A; Namiki M; Hirano K
    J Androl; 2008; 29(2):207-12. PubMed ID: 17916567
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.